No, eGFR is NOT normal in acute kidney injury (AKI)—it is reduced or declining
By definition, AKI involves a decline in kidney function, which manifests as a fall in eGFR, a rise in serum creatinine, or reduced urine output. The estimated glomerular filtration rate (eGFR) decreases during AKI, though the magnitude and timing of this decline varies based on the severity and stage of injury 1.
Understanding eGFR Changes in AKI
The Fundamental Problem with eGFR in Acute Settings
Creatinine-based eGFR equations systematically overestimate true GFR during AKI because they were developed for stable chronic kidney disease (CKD), not acute conditions 1, 2. When AKI occurs:
- True GFR drops rapidly (within hours)
- Serum creatinine rises slowly (over days) before reaching steady state
- eGFR calculations lag behind the actual kidney function decline 1
This creates a dangerous window where eGFR appears falsely reassuring while true kidney function has already deteriorated significantly 2.
Quantifying the Overestimation
Research demonstrates the magnitude of this problem:
- In critically ill adults with severe oligoanuric AKI (true GFR ≤15 mL/min/1.73 m²), creatinine-based equations overestimated GFR by 17-50 mL/min/1.73 m² 2
- This overestimation persisted through the fourth day of AKI 2
- Even kinetic eGFR equations showed limits of agreement exceeding 40 mL/min/1.73 m² when compared to measured GFR 3
How AKI is Defined Using eGFR
Adult Criteria (KDIGO)
AKI staging incorporates eGFR decline 1, 4:
- Stage 1: 1.5-1.9× baseline creatinine OR ≥0.3 mg/dL increase within 48 hours
- Stage 2: 2.0-2.9× baseline creatinine
- Stage 3: 3.0× baseline creatinine OR creatinine ≥4.0 mg/dL OR initiation of dialysis
Pediatric Criteria (pRIFLE)
Children are staged by percentage fall in eGFR 1:
- Stage R (Risk): ≥25% eGFR decrease
- Stage I (Injury): ≥50% eGFR decrease
- Stage F (Failure): ≥75% eGFR decrease OR eGFR <35 mL/min/1.73 m²
The example provided shows a 7-year-old with baseline eGFR of 88 mL/min/1.73 m² dropping to 65 mL/min/1.73 m² (25% fall) during AKI 1.
Critical Clinical Pitfalls
The "Normal" eGFR Trap
A patient can have significant AKI even with an eGFR that appears within normal range if:
- Their baseline eGFR was supranormal (>105 mL/min/1.73 m²)
- They've experienced acute decline but haven't yet crossed traditional thresholds
- Creatinine hasn't equilibrated to reflect true GFR loss
Recent evidence shows patients with high baseline eGFR (≥105 mL/min/1.73 m²) have doubled AKI risk (adjusted OR 2.143) 5, creating a U-shaped relationship between baseline eGFR and AKI incidence.
Medication Dosing Hazard
The overestimation of eGFR during AKI creates substantial risk for medication toxicity 2. Clinicians relying on calculated eGFR may:
- Underdose antimicrobials when higher doses are needed
- Overdose renally-cleared medications, causing toxicity
- Delay recognition of need for renal replacement therapy
When eGFR Equations Fail Most
Creatinine-based eGFR is particularly unreliable when 1:
- Creatinine kinetics are unstable (first 48-72 hours of AKI)
- Volume of distribution is extreme or variable (critical illness, fluid overload)
- Multiple renal insults occur over time
- Baseline kidney function is unknown
Alternative Approaches
Cystatin C-Based eGFR
Cystatin C-based eGFR demonstrates superior discrimination for mortality and progression in AKI compared to creatinine-based estimates 6. It responds more rapidly to GFR changes and is less affected by muscle mass variations.
Direct Measurement
When precise GFR assessment is critical, measured GFR using iohexol or radioisotopic methods provides the gold standard 7, 3, though this is rarely practical in acute settings.
Bottom Line for Clinical Practice
Never assume eGFR is "normal" or accurate during AKI. Instead:
- Use absolute creatinine changes and urine output as primary AKI indicators
- Recognize that eGFR calculations lag behind true kidney function by days
- Consider cystatin C-based eGFR when available for more accurate assessment
- Adjust medication dosing conservatively, assuming worse kidney function than eGFR suggests
- Monitor trends rather than single values
- Be especially vigilant in patients with high baseline eGFR (≥105 mL/min/1.73 m²) who may develop AKI while maintaining "normal-appearing" eGFR values 5